Drais Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Bridgewater NJ United States (2007)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2012
NCT01612039
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Drais Pharmaceuticals, Inc. | Seldar Pharma, Inc.